Prognosis of myocardial infection in diabetic patients: Results of the USIK survey;Pronostic de l'infarctus du myocarde chez le patient diabetique: Resultats de l'etude epidemiologique USIK

Presse Medicale

Volumn 27, Issue 21, 1998, Pages 1003-1008

  Genes N ^a,e   Vaur, L ^a   Dubroca, I ^b   Etienne, S ^a   Cambou, J P ^c   Danchin, N ^d  

^a Laboratoires Diamant   (France)

^b HMR France   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e Gamme Cardiologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

EID: 0032513914     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974 ; 23:105-11.
2. Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985 ; 8:230-4.
3. Kannel W. Lipids, diabetes and coronary heart disease: insights from the Framingham study. Am Heart J 1985 ; 110:1110-7.
4. Abbud ZA, Schindler ZM, Wilson AC, Kostis JB for the Myocardial Infarction Data Acquisition System Study Group. Effects of diabetis mellitus on short and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J 1995 ; 130:51-8
5. Behar S, Boyko V, Reicher-Reiss H, Goldbourt U for the SPRINT Study Group. Ten-year survival after acute myocardial infarction : comparison of patients with and without diabetes. Am Heart J 1997 ; 133:290-6.
6. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG, on behalf of GISSI-2 Investigators. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993 ; 22:1788-94.
7. Mak KH, Moliterno DJ, Granger CB et al. for the Gusto-I investigators. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol 1997 ; 30:171-9.
8. Kannel WB, Mc Gee DL. Diabetes and cardiovascular risk factors : the Framingham study. Circulation 1979 ; 59:8-13.
9. Stone PH, Muller JE, Hartwell T et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary artery disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989 ; 14:49-57.
10. Lee KL, Woodlief LH, Topol EJ et al. Predictors of 30-day mortality in the era of reperfusion of acute myocardial infarction : results from an international trial of 41021 patients. Circulation 1995 ; 91:1659-68.
11. Cambou JP, Genès N, Vaur L et al. Epidémiologie de l'infarctus du myocarde en France : spécificités régionales. Arch Mal Cœur 1997 ; 90:1511-19.
12. Danchin N, Vaur L, Genès N et al. Management of acute myocardial infarction in intensive care units in 1995: a notion-wide French survey of practice and early hospital results. J Am Coll Cardiol 1997 ; 30:1598-605.
13. Barbash GI, White HD, Modan M, Van de Werf F and the investigators of the International Tissue Plasminogen/Streptokinase Mortality Trial. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic agents. J Am Coll Cardiol 1993 ; 22:707-13.
14. Rouleau JL, Talajic M, Sussex B et al. Myocardial infarction in patients in the 1990s. Their risk factors, stratification and survival in Canada : the Canadian Assessment of Myocardial Infarction (CAMI) study. J Am Coll Cardiol 1996 ; 27:1119-27.
15. Kober L, Torp-Pedersen C, Ottesen M, Rasmussen S, Lessing M, Skagen K on behalf of the TRACE study group. Influence of gender on short- and long-term mortality after acute myocardial infarction. Am J Cardiol 1996 ; 76:1052-6.
16. Brandt CM, Wees-Ponction A, Nisand G et al. Survie dans l'infarctus du myocarde au stade aigu dans un groupe de 369 patients admis consécutivement entre 1988 et 1992. Arch Mal Cœur 1994 ; 87:861-8.
17. Malmberg K, Ryden L, Hamsten A, Herlitz J, Naldenström A, Wedel H. On behalf of the DIGAMI Study Group. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart 1996 ; 17:1337-44.